Literature DB >> 11204805

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

C P Felley1, I Corthésy-Theulaz, J L Rivero, P Sipponen, M Kaufmann, P Bauerfeind, P H Wiesel, D Brassart, A Pfeifer, A L Blum, P Michetti.   

Abstract

OBJECTIVE: The supernatant of Lactobacillus johnsonii La1 culture was shown to be bactericidal and to have a partial, acid-independent suppressive effect on Helicobacter pylori in humans. The aim of the present study was to investigate the effect of L. johnsonii La1-acidified milk (LC-1) on H. pylori infection. DESIGN AND METHODS: Fifty-three volunteers infected with H. pylori as determined by positive 13C-urea breath test and positive serology were randomized to receive either LC-1 or a placebo 180 ml twice a day for 3 weeks. All subjects also received clarithromycin 500 mg bid during the last two weeks of acidified milk therapy. Oesophagogastroduodenoscopy and biopsies were performed at inclusion and repeated 4-8 weeks after the end of the treatment. H. pylori infection was confirmed by urease test and histology. H. pylori density and inflammation were scored using a modified Sydney classification.
RESULTS: LC-1 ingestion induced a decrease in H. pylori density in the antrum (P= 0.02) and the corpus (P= 0.04). LC-1 also reduced inflammation and gastritis activity in the antrum (P= 0.02 and P= 0.01, respectively) and of activity in the corpus (P= 0.02). Clarithromycin eradicated H. pylori in 26% of the subjects; LC-1 did not improve the antibiotic effect.
CONCLUSION: These results suggest that H. pylori infection and gastritis can be down-regulated by LC-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204805     DOI: 10.1097/00042737-200101000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  17 in total

Review 1.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

2.  Lactobacillus reuteri in the treatment of Helicobacter pylori infection.

Authors:  Maria Pina Dore; Marianna Cuccu; Gianni Mario Pes; Alessandra Manca; David Yates Graham
Journal:  Intern Emerg Med       Date:  2013-11-01       Impact factor: 3.397

3.  Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.

Authors:  Mohamed H Emara; Salem Y Mohamed; Hesham R Abdel-Aziz
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

4.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori.

Authors:  Luc De Vuyst; Pascal Vincent; Eleftherios Makras; Frédéric Leroy; Bruno Pot
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

Review 6.  Probiotics in clinical conditions.

Authors:  Philippe R Marteau
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

7.  The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 8.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 9.  Efficacy of fermented milk and whey proteins in Helicobacter pylori eradication: a review.

Authors:  Aarti Sachdeva; Swapnil Rawat; Jitender Nagpal
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 10.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.